A new set of May 2013 investor due diligence research on biotech stocks provided by Mike O'Neill has been posted, covering financials and upcoming catalysts for each biotech stock. These summaries are compiled via communication with company investor relations personnel or via Mike's thorough and independent research.
This round of responses features InterMune Inc $ITMN, Biocryst Pharmaceuticals $BCRX, Ironwood Pharmaceuticals $IRWD, Prothena Corp $PRTA, and Genspera Inc $GNSZ.
Check out the complete index of all IR Questions and Answers if you missed the previous editions - now covering ~75 biotech and pharmaceutical companies!
This round of responses features InterMune Inc $ITMN, Biocryst Pharmaceuticals $BCRX, Ironwood Pharmaceuticals $IRWD, Prothena Corp $PRTA, and Genspera Inc $GNSZ.
Check out the complete index of all IR Questions and Answers if you missed the previous editions - now covering ~75 biotech and pharmaceutical companies!
RSS Feed
